Stay updated with breaking news from Tissue Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Integra LifeSciences (NASDAQ:IART – Get Rating) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided EPS guidance of $3.43-$3.51 for the period, compared to the consensus EPS estimate of $3.48. The company issued revenue guidance of $1.60 billion-$1.62 billion, compared to the consensus revenue estimate of $1.61 billion. Integra […]
Integra LifeSciences (NASDAQ:IART – Get Rating) updated its FY 2023 earnings guidance on Thursday. The company provided earnings per share guidance of $3.43-$3.51 for the period, compared to the consensus earnings per share estimate of $3.48. The company issued revenue guidance of $1.60 billion-$1.62 billion, compared to the consensus revenue estimate of $1.61 billion. Integra […]
Integra LifeSciences (NASDAQ:IART – Get Rating) updated its second quarter 2023 earnings guidance on Thursday. The company provided EPS guidance of $0.75-$0.79 for the period, compared to the consensus EPS estimate of $0.85. The company issued revenue guidance of $396.00 million-$400.00 million, compared to the consensus revenue estimate of $404.78 million. Integra LifeSciences also updated […]
Integra LifeSciences (NASDAQ:IART – Get Rating) issued an update on its second quarter 2023 earnings guidance on Thursday morning. The company provided earnings per share guidance of $0.75-$0.79 for the period, compared to the consensus earnings per share estimate of $0.85. The company issued revenue guidance of $396.00 million-$400.00 million, compared to the consensus revenue […]
Integra LifeSciences (NASDAQ:IART – Get Rating) issued an update on its second quarter 2023 earnings guidance on Thursday morning. The company provided EPS guidance of $0.75-$0.79 for the period, compared to the consensus EPS estimate of $0.85. The company issued revenue guidance of $396.00 million-$400.00 million, compared to the consensus revenue estimate of $404.78 million. […]